ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,013.13
      -1.71%
      US Tech 100
      21,039.16
      -2.09%
      Dow Jones
      43,428.02
      -1.69%
      Brent Oil
      73.96
      -0.20%
      Bitcoin
      95,695.56
      -0.60%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Lyra Therapeutics Inc (LYRA) Quote

      Lyra Therapeutics Inc

      Lyra Therapeutics Inc (LYRA)

      NASDAQ
      0.2057
      0.0081
      (4.10%)
      Closed February 24 4:00PM
      Delayed by 15 minutes
      0.2016
      -0.0041
      (-1.99%)
      After Hours: 7:19PM
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      0.2016
      Bid
      0.1907
      Ask
      0.228
      Volume
      1,103,738
      0.1977 Day's Range 0.2154
      0.1625 52 Week Range 6.79
      Market Cap
      13.196M
      Previous Close
      0.1976
      Open
      0.204
      Last Trade
      10
      @
      0.2109
      Last Trade Time
      Financial Volume
      $ 227,665
      VWAP
      0.206267
      Average Volume (3m)
      1,350,107
      Shares Outstanding
      65,457,648
      Dividend Yield
      -
      PE Ratio
      -0.22
      Earnings Per Share (EPS)
      -0.96
      Revenue
      1.56M
      Net Profit
      -62.68M

      About Lyra Therapeutics Inc

      Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. The company's technology platform, XTreo, is designed to precis... Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. The company's technology platform, XTreo, is designed to precisely and consistently deliver medicines directly to the affected tissue for sustained periods with a single administration. Show more

      Sector
      Surgical,med Instr,apparatus
      Industry
      Surgical,med Instr,apparatus
      Website
      lyratherapeutics.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Lyra Therapeutics Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker LYRA. The last closing price for Lyra Therapeutics was $0.20. Over the last year, Lyra Therapeutics shares have traded in a share price range of $ 0.1625 to $ 6.79.

      Lyra Therapeutics currently has 65,457,648 shares outstanding. The market capitalization of Lyra Therapeutics is $12.93 million. Lyra Therapeutics has a price to earnings ratio (PE ratio) of -0.22.

      Ask ADVFN Intelligence (AI)

      LYRA Latest News

      More News

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      January 10 2025
      LYRA (4.10%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      January 10 2025
      LYRA (4.10%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      January 10 2025
      LYRA (4.10%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      December 13 2024
      LYRA (4.10%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      December 11 2024
      LYRA (4.10%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      December 11 2024
      LYRA (4.10%)

      Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
      Edgar (US Regulatory)
      November 14 2024
      LYRA (4.10%)

      Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
      Edgar (US Regulatory)
      November 14 2024
      LYRA (4.10%)

      Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
      Edgar (US Regulatory)
      November 14 2024
      LYRA (4.10%)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.0086-4.091341579450.21020.21620.19439560450.20348063CS
      40.01467.807486631020.1870.21880.17528860070.19438978CS
      120.009650.1920.2450.163513501070.19865325CS
      26-0.1259-38.44274809160.32750.34260.162513951560.21859087CS
      52-4.7884-95.95991983974.996.790.162518162750.59272095CS
      156-4.4684-95.68308351184.678.180.16257043861.13628103CS
      260-20.7984-99.0421220.16254737961.88253081CS

      LYRA - Frequently Asked Questions (FAQ)

      What is the current Lyra Therapeutics share price?
      The current share price of Lyra Therapeutics is $ 0.2016
      How many Lyra Therapeutics shares are in issue?
      Lyra Therapeutics has 65,457,648 shares in issue
      What is the market cap of Lyra Therapeutics?
      The market capitalisation of Lyra Therapeutics is USD 12.93M
      What is the 1 year trading range for Lyra Therapeutics share price?
      Lyra Therapeutics has traded in the range of $ 0.1625 to $ 6.79 during the past year
      What is the PE ratio of Lyra Therapeutics?
      The price to earnings ratio of Lyra Therapeutics is -0.22
      What is the cash to sales ratio of Lyra Therapeutics?
      The cash to sales ratio of Lyra Therapeutics is 8.82
      What is the reporting currency for Lyra Therapeutics?
      Lyra Therapeutics reports financial results in USD
      What is the latest annual turnover for Lyra Therapeutics?
      The latest annual turnover of Lyra Therapeutics is USD 1.56M
      What is the latest annual profit for Lyra Therapeutics?
      The latest annual profit of Lyra Therapeutics is USD -62.68M
      What is the registered address of Lyra Therapeutics?
      The registered address for Lyra Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
      What is the Lyra Therapeutics website address?
      The website address for Lyra Therapeutics is lyratherapeutics.com
      Which industry sector does Lyra Therapeutics operate in?
      Lyra Therapeutics operates in the SURGICAL,MED INSTR,APPARATUS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      MLGOMicroAlgo Inc
      $ 6.3767
      (454.50%)
      		531.54M
      BOXLBoxlight Corporation
      $ 3.1099
      (51.70%)
      		1.84M
      GDEVGDEV Inc
      $ 20.90
      (46.56%)
      		264.44k
      IVVDInvivyd Inc
      $ 1.7501
      (44.64%)
      		37.75M
      UPCUniverse Pharmaceuticals Inc
      $ 0.2003
      (40.56%)
      		420.21M
      DOYUDouYu International Holdings Ltd
      $ 7.19
      (-55.31%)
      		1.28M
      MNDRMobile health Network Solutions
      $ 0.5048
      (-46.29%)
      		18.61M
      BLUEbluebird bio Inc
      $ 4.09
      (-41.90%)
      		5.44M
      GCLGCL Global Holdings Ltd
      $ 3.83
      (-31.48%)
      		635.26k
      AXTIAXT Inc
      $ 1.57
      (-31.44%)
      		6.66M
      MLGOMicroAlgo Inc
      $ 6.3767
      (454.50%)
      		531.54M
      UPCUniverse Pharmaceuticals Inc
      $ 0.2003
      (40.56%)
      		420.21M
      ADTXAditxt Inc
      $ 0.0922
      (-22.39%)
      		278.25M
      NVDANVIDIA Corporation
      $ 134.43
      (-4.05%)
      		228.14M
      HOLOMicroCloud Hologram Inc
      $ 1.565
      (31.51%)
      		190.81M

      LYRA Discussion

      View Posts
      Rein07 Rein07 1 month ago
      https://finance.yahoo.com/news/lyra-therapeutics-lyra-upgraded-strong-170012660.html
      👍️0
      glenn1919 glenn1919 2 months ago
      lyra.................................https://stockcharts.com/h-sc/ui?s=lyra&p=W&b=5&g=0&id=p86431144783

















      lostintheshuffle.......................8
      👍️0
      tw0122 tw0122 2 months ago
      .24
      👍️0
      tw0122 tw0122 2 months ago
      .24
      👍️0
      Dennis14 Dennis14 6 months ago
      Earnings out.
      👍️0
      Dennis14 Dennis14 6 months ago
      Big buys after hours 86000 buy and (3)50000 buys
      👍️0
      Dennis14 Dennis14 6 months ago
      It now says 13th after hours. We will see
      👍️0
      Dennis14 Dennis14 6 months ago
      Earnings supposed to be on the 12th Aug.
      👍️0
      Dennis14 Dennis14 7 months ago
      I just read. Earnings coming out next week or the week after.
      👍️0
      Dennis14 Dennis14 7 months ago
      Earnings coming out any day now.
      👍️0
      BigBadWolf BigBadWolf 8 months ago
      DDAmanda finds them early so that Han's (he provided the name pumping testimonials) can sell off his early buys while he's pumping to his paid subscribers. Want proof DDAmanda $subscribers PM me for verification or simply check my posting history for the mud this P_G waddles in..
      https://lyratherapeutics.com/
      👍️0
      Zardiw Zardiw 8 months ago
      Well, 6 weeks ago she was $5: $LYRA Chart from #DDAmanda - #1 Stock Screener :

      Find Winners Early:



      Z
      👍️0
      Termite7 Termite7 8 months ago
      Who? .....How high for LYRA? .......Thanks!!!
      👍️0
      Zardiw Zardiw 8 months ago
      Nice list.........$LYRA is due.......according to #DDAmanda.

      Z
      👍️0
      Termite7 Termite7 8 months ago
      Oversold!!! ......https://finviz.com/screener.ashx?v=110&s=ta_oversold&o=change
      👍️0
      Zardiw Zardiw 9 months ago
      $LYRA Book Value is $1.27 ......trading at .34 ........or 1/4 the BV........

      Z
      👍️ 1
      INV4 INV4 9 months ago
      LYRA Institutional Holdings
      Ownership Summary

      Institutional Ownership • 74.73%
      Total Shares Outstanding (millions) • 61
      Total Value of Holdings (millions) • $16

      Active Positions • Holders • Shares
      Increased Positions • 54 • 9,224,767
      Decreased Positions • 19 • 6,026,566
      Held Positions • 11 • 30,304,888

      Institutional Holders: 84
      Total Shares Held: 45,556,221

      $BLEG

      LYRA Analyst Research
      Lyra Therapeutics, Inc. Common Stock (LYRA) Analyst Research
      LYRA Earnings Consensus

      CONSENSUS
      Buy
      Based on 6 analysts offering recommendations for 'LYRA'.

      Analyst Price Targets
      CONSENSUS
      $0.95

      Based on analysts offering 12 month price targets for LYRA in the last 3 months.
      The average price target is $0.95 with a high estimate of $2 and a low estimate of $0.35.

      https://www.nasdaq.com/market-activity/stocks/lyra/analyst-research

      $LYRA
      👍️0
      Zardiw Zardiw 9 months ago
      $LYRA Bounce anytime now...............

      Z
      👍️ 1
      INV4 INV4 9 months ago
      Let's see when it bounces 😀

      $LYRA
      👍️0
      glenn1919 glenn1919 9 months ago
      LYRA.........................................https://stockcharts.com/h-sc/ui?s=LYRA&p=W&b=5&g=0&id=p86431144783
      👍️0
      Zardiw Zardiw 10 months ago
      Yes. Expecting a nice $LYRA Bounce..............

      Z
      👍️0
      Dennis14 Dennis14 10 months ago
      Relative Strength Index is at 12 this is way over sold.
      👍️0
      Zardiw Zardiw 10 months ago
      $LYRA Book Value: $1.28 ....currently at .43 ...

      Z
      👍️0
      Dennis14 Dennis14 10 months ago
      Bought in this morning at .42, I believe this will be back to at least 1 or 2 bucks.
      👍️0
      axelvento axelvento 10 months ago
      game over: announced topline results from the Phase 3 ENLIGHTEN 1 trial evaluating LYR-210 for the treatment of chronic rhinosinusitis (CRS). ENLIGHTEN 1 did not meet its primary endpoint
      👍️0
      Monksdream Monksdream 10 months ago
      LYRA under $10

      👍️0
      Monksdream Monksdream 11 months ago
      LYRA under $10
      👍️0
      TrendTrade2016 TrendTrade2016 11 months ago
      LYRA...NOT HOLDING INTO ER
      👍️0
      TrendTrade2016 TrendTrade2016 11 months ago
      LYRA...LETS SEE 7.00
      👍️0
      TrendTrade2016 TrendTrade2016 11 months ago
      LYRA...EXPLODING!!!!!
      👍️0
      Monksdream Monksdream 11 months ago
      LYRA 10Q due March 14
      👍️0
      TrendTrade2016 TrendTrade2016 11 months ago
      LYRA...BEAUTIFUL BREAK OUT
      👍️0
      TrendTrade2016 TrendTrade2016 11 months ago
      LYRA....BIO BEAST!
      👍️0
      TrendTrade2016 TrendTrade2016 11 months ago
      LYRA...HERE WE GO
      👍️0
      TrendTrade2016 TrendTrade2016 11 months ago
      LYRA...MOVES ON AIR!!!
      👍️0
      TrendTrade2016 TrendTrade2016 11 months ago
      LYRA...HERE WE GO
      👍️0
      Monksdream Monksdream 12 months ago
      LYRA 10Q due March 7
      👍️0
      TrendTrade2016 TrendTrade2016 12 months ago
      LYRA..WHAT A BEAUTY...NOBODY TALKING!!!
      👍️0
      TrendTrade2016 TrendTrade2016 12 months ago
      LYRA...NEXT BIO BEAST READY TO BEAST
      👍️0
      Monksdream Monksdream 1 year ago
      LYRA No 3 on the Barchart Top 10
      https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
      👍️0

      Your Recent History

      NASDAQ
      LYRA
      Lyra Therapeutics
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads